Aytu Biopharma, Inc (AYTU): Operating Cash Flow
$3.28M
Year ended 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $3.28M | n/m | 2026-09-22, From 2025-07-01 |
| 2025-06-30 | -$1.94M | n/m | 2026-09-22, From 2024-07-01 |
| 2024-06-30 | -$1.39M | n/m | 2025-09-23, From 2023-07-01 |
| 2023-06-30 | -$5.13M | n/m | 2024-09-26, From 2022-07-01 |
| 2022-06-30 | -$28.82M | n/m | 2023-10-12, From 2021-07-01 |
| 2021-06-30 | -$25.96M | n/m | 2022-09-27, From 2020-07-01 |
| 2020-06-30 | -$28.37M | n/m | 2021-09-28, From 2019-07-01 |
| 2019-06-30 | -$13.83M | n/m | 2020-10-06, From 2018-07-01 |
| 2018-06-30 | -$15.94M | n/m | 2019-09-26, From 2017-07-01 |
| 2017-06-30 | -$13.83M | n/m | 2018-09-06, From 2016-07-01 |
| 2016-06-30 | -$10.66M | n/m | 2017-08-31, From 2015-07-01 |
| 2015-06-30 | -$6.63M | n/m | 2016-09-01, From 2014-07-01 |
| 2014-06-30 | -$5.50M | n/a | 2015-09-28, From 2013-07-01 |
| No annual figure between 2012-08-31 and 2014-06-30. | |||
| 2012-08-31 | -$37.8K | n/m | 2014-11-26, From 2011-09-01 |
| 2011-08-31 | -$64.8K | n/a | 2012-11-29, From 2010-09-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Aytu Biopharma, Inc (AYTU) | 2026-06-30 | $3.28M | n/m |
| Nektar Therapeutics (NKTR) | 2025-12-31 | -$208.51M | n/m |
| Integrated Biopharma Inc (INBP) | 2025-06-30 | $2.06M | +119.0% |
| Journey Medical Corp (DERM) | 2025-12-31 | -$12.44M | n/m |
| Agios Pharmaceuticals, Inc. (AGIO) | 2025-12-31 | -$372.98M | n/m |
| Q32 Bio Inc. (QTTB) | 2025-12-31 | -$33.54M | n/m |
| Tango Therapeutics, Inc. (TNGX) | 2025-12-31 | -$138.89M | n/m |
| Nuvation Bio Inc. (NUVB) | 2025-12-31 | -$173.43M | n/m |
| Fortress Biotech, Inc. (FBIO) | 2025-12-31 | -$65.78M | n/m |
Compare AYTU, NKTR, INBP, DERM side by side · Screen every company in Pharmaceutical Preparations ↗